Fennec Pharmaceuticals Inc.
Status: Publicly traded
Direct answer
Fennec Pharmaceuticals Inc. is publicly traded on NASDAQ under the ticker FENC.
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex...
Can you invest in Fennec Pharmaceuticals Inc.?
Yes. Fennec Pharmaceuticals Inc. is publicly traded on NASDAQ under the ticker FENC.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Fennec Pharmaceuticals Inc.
Detailed equity research is provided by MarketSnap.